Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Mutations in TBX3 cause horses to have more even hair color instead of Dun camouflage.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

MicroRNAs may help diagnose and treat hair loss disorders.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

miR-200c-3p could help diagnose and treat alopecia areata.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Genes like MC1R, TYR, MITF, ASIP, and KIT determine horse and donkey coat colors and affect breeding and health.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

New medications could improve treatment for severe alopecia areata in Australia.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Manipulating cell cleanup processes could help treat hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Only one of the two K16 genes on chromosome 17 makes a functional protein for keratin filaments.

Keratin 17 gene mutations cause both steatocystoma multiplex and pachyonychia congenita type 2.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.